Loading...

EssilorLuxottica S.A.

EI.SWSIX
Healthcare
Medical - Specialties
CHF117.00
CHF0.00(0.00%)
Swiss Market is Open • 16:35

EssilorLuxottica S.A. Fundamental Analysis

EssilorLuxottica S.A. (EI.SW) shows weak financial fundamentals with a PE ratio of 41.36, profit margin of 8.13%, and ROE of 6.04%. The company generates $46.3B in annual revenue with moderate year-over-year growth of 4.38%.

Key Strengths

PEG Ratio-11.99

Areas of Concern

ROE6.04%
Current Ratio0.99
We analyze EI.SW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 49.3/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
49.3/100

We analyze EI.SW's fundamental strength across five key dimensions:

Efficiency Score

Weak

EI.SW struggles to generate sufficient returns from assets.

ROA > 10%
3.62%

Valuation Score

Moderate

EI.SW shows balanced valuation metrics.

PE < 25
41.36
PEG Ratio < 2
-11.99

Growth Score

Weak

EI.SW faces weak or negative growth trends.

Revenue Growth > 5%
4.38%
EPS Growth > 10%
1.76%

Financial Health Score

Moderate

EI.SW shows balanced financial health with some risks.

Debt/Equity < 1
0.44
Current Ratio > 1
0.99

Profitability Score

Weak

EI.SW struggles to sustain strong margins.

ROE > 15%
6.04%
Net Margin ≥ 15%
8.13%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is EI.SW Expensive or Cheap?

P/E Ratio

EI.SW trades at 41.36 times earnings. This suggests a premium valuation.

41.36

PEG Ratio

When adjusting for growth, EI.SW's PEG of -11.99 indicates potential undervaluation.

-11.99

Price to Book

The market values EssilorLuxottica S.A. at 2.46 times its book value. This may indicate undervaluation.

2.46

EV/EBITDA

Enterprise value stands at 12.57 times EBITDA. This signals the market has high growth expectations.

12.57

How Well Does EI.SW Make Money?

Net Profit Margin

For every $100 in sales, EssilorLuxottica S.A. keeps $8.13 as profit after all expenses.

8.13%

Operating Margin

Core operations generate 11.80 in profit for every $100 in revenue, before interest and taxes.

11.80%

ROE

Management delivers $6.04 in profit for every $100 of shareholder equity.

6.04%

ROA

EssilorLuxottica S.A. generates $3.62 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.62%

Following the Money - Real Cash Generation

Operating Cash Flow

EssilorLuxottica S.A. produces operating cash flow of $8.60B, showing steady but balanced cash generation.

$8.60B

Free Cash Flow

EssilorLuxottica S.A. generates strong free cash flow of $6.12B, providing ample flexibility for dividends, buybacks, or growth.

$6.12B

FCF Per Share

Each share generates $8.13 in free cash annually.

$8.13

FCF Yield

EI.SW converts 3.93% of its market value into free cash.

3.93%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

41.36

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-11.99

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.46

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.36

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.44

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.99

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.06

vs 25 benchmark

ROA

Return on assets percentage

0.04

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How EI.SW Stacks Against Its Sector Peers

MetricEI.SW ValueSector AveragePerformance
P/E Ratio41.3629.17 Worse (Expensive)
ROE6.04%701.00% Weak
Net Margin8.13%-43676.00% (disorted) Weak
Debt/Equity0.440.34 Weak (High Leverage)
Current Ratio0.994.45 Weak Liquidity
ROA3.62%-18965.00% (disorted) Weak

EI.SW outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews EssilorLuxottica S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

45.77%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

109.46%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

41.28%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ